DEXRENT financials
A multi-period view of the public annual-account figures reported for DEXRENT, with comparable measures and links to available source documents.
Company overviewRegistry number
0459737834
Fiscal coverage
2024–2025
Public sources
cbso_bulk
Data updated
Jul 28, 2026
Financial evidence
Latest movements for DEXRENT
2025 versus 2024
- Operating line
- €32,418
- EBITDA
- €27,882
- Total assets
- €325,077
- Equity
- €103,337
-10.8%
-12.9%
+26.6%
+6.7%
EBITDA margin +86% · Equity ratio +31.8%
Multi-year filings
Source: NBB/CBSOFiled annual accounts by fiscal year
Public regulator-filed figures across 2 years.
Fiscal year | Gross margin | EBITDA | Total assets | Equity | Filing |
|---|---|---|---|---|---|
| 202531 Dec 2025 | €32,418 | €27,882 | €325,077 | €103,337 | - |
| 202431 Dec 2024 | €36,332 | €32,020 | €256,745 | €96,890 | - |
Figures reproduce public filings and may use country-specific accounting definitions. They are not audited by Upswitch.